The infrequency of FH-deficient uterine leiomyomas and unique characteristics, such as a genetic link to HLRCC and hereditary leiomyomatosis, already identify the diagnosis and treatment as a unique challenge. The gene discussed is FH; the disease is uterine corpus leiomyoma.